1Fowler V L,Paton D J,Rieder E,et al.Chimeric foot-and-mouth disease viruses;evaluation of their efficacy as potential marker vaccines in cattle[J].Vaccine,2008,26(16):1 982-1 989.
2Van Rensburg H G,Mason P W.Construction and evaluation of a recombinant foot-and-mouth disease virus:implications for inactivated vaccine production[J].Ann NY Acad Sci,2002,969:83-87.
3Bertoletti A,Gehring A.Therapeutic vaccination and novel strategies to treat chronic HBV infection[J].Expert Rev Gastroenterol Hepatol,2009,3 (5):561-569.
4Chen W,Liu M,Jiao Y,et al.Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo[J].Virol,2006,80(7):3 559-3 556.
6Kanduc D."Self-nonself" peptides in the design of vaccines[J].Curr Pharm Des,2009,15(28):3283-3289.
7Sun J B,Czerkinsky C,Holmgren J.Mucosally induced immunological tolerance,regulatory T cells and the adjuvant effect by cholera toxin B subunit[J].Scand J Immunol,2010,71(1):1-11.
8Amanna I J,Slifka M K.Wanted,dead or alive:new viral vaccines[J].Antiviral Res,2009,84(2):119-130.
9Roper R L,Rehm K E.SARS vaccines:where are we[J].Expert Rev Vaccines,2009,8(7):887-898.
